Pivotal phase III trial of FP 1097 in women with urinary incontinence or overactive bladder

Trial Profile

Pivotal phase III trial of FP 1097 in women with urinary incontinence or overactive bladder

Planning
Phase of Trial: Phase III

Latest Information Update: 12 Jan 2011

At a glance

  • Drugs Oxybutynin (Primary)
  • Indications Overactive bladder; Urinary incontinence
  • Focus Registrational; Therapeutic Use
  • Most Recent Events

    • 12 Jan 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top